Luteolin mitigates inflammatory organ injury by targeting XIAP to block PANoptosis and mitochondrial dysfunction. - Shi FL; Lv YF; Luo SQ; Sun YX; Wen XQ; Ren YX; Yang YX; Yu P; Chen QF; Yang XH; Xu S; Qing J; et al. (International immunopharmacology, 2026)